Posts tagged “Biotech & Life Science”
He's been called the "biofather" of North Carolina's growing life science industry, and Dr. Charles Hamner is among the first five people selected for WRAL TechWire's Hall of Fame. The former head of the N.C. Biotechnology Center and long a champion of North Carolina, Hamner talks about his distinguished career, achievements and disappointments in an exclusive Q&A.
In reporting a 20th consecutive quarter of a drop in income, IBM's healthcare related businesses stand out as a bright spot amid otherwise anemic services performance, says Technology Business Research Analyst John Caucis.
WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.
The first five recipients of WRAL TechWire's Hall of Fame honors for lifetime achievement are well-known contributors to the growing, evolving success of North Carolina's high tech, life science and entrepreneurial ecosystem.
Raleigh-based Valencell, which makes biometric sensors for wearables and Finland's Firstbeat, which provides physiological analytics, say they are collaborating "to explore to full potential of what can biometric wearables can achieve."
Clinical data company TARGET PharmaSolutions of Chapel Hill will collaborate with Dublin-based Allergan, a global pharmaceutical company, to study a major liver disease and future treatment options for it.
Researchers at the UNC School of Medicine and Duke are part of a project that has received a $3.2 million federal grant to develop a test for the Zika virus they hope will provide accurate results for a wide range of time between when an individual is potentially exposed to when he or she is tested for the virus.
In today's roundup of technology news: a compound found in aged cheese and mushrooms may prevent liver cancer and extend life; million dollar flying car coming; dry your clothes in half the time with sound.
A genetic test developed by MultiGEN Diagnostics of Greensboro is 1,000 times more sensitive than current methods in detecting a key mutation in cancer, according to a newly published scientific paper.
The North Carolina Biotechnology Center awarded 14 loans and grants totaling $1.6 million to companies, universities and other bioscience entities in the third quarter of its 2016-2017 fiscal year ending March 31.
Clinical Sensors Inc., a small diagnostic device company in Research Triangle Park, has won two grants totaling more than $1.5 million from the National Institutes of Health (NIH) to support the development of its point-of-care device that measures a patient's blood nitric oxide level within a few seconds.
NeuroTronik Inc. of Durham has closed on $23.1 million in Series B preferred stock financing to advance its therapy for treating acute heart failure in hospitals.